895464

Manhattan Reproductive Medicine, PC — FEI 3004753417

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 18, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Citations

IDCFRDescription
1223021 CFR 1271.50(a)Responsible person to determine, document
1224721 CFR 1271.55(d)(2)Accurate, indelible, legible
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence
1227821 CFR 1271.75(a)(2)Risks associated with xenotransplantation
1228721 CFR 1271.80(c)Kits not FDA approved, specifically labeled